關於 theratechnologies trogarzo ，我們在網路上蒐集到這些相關的討論、資訊與評價

#11. Theratechnologies Announces FDA Approval of ... - NATAP

Theratechnologies Announces FDA Approval of Breakthrough Therapy, Trogarzo™ (ibalizumab-uiyk) Injection, the First HIV-1 Inhibitor and Long-Acting ...

#12. Search Orphan Drug Designations and Approvals - FDA

Trade Name: Trogarzo ... Sponsor: Theratechnologies Inc. ... Approved Labeled Indication: TROGARZO, in combination with other antiretroviral(s), ...

#13. Theratechnologies - POZ Magazine

FDA Approves Antibody Treatment Trogarzo for Multidrug-Resistant HIV · The intravenous medication, which should be used with standard antiretrovirals, ...

#14. FDA Approves Trogarzo for 30-Second IV Push, Simplifying ...

The FDA approved ibalizumab-uiyk (Trogarzo, Theratechnologies) for administration by IV push, a method by which the undiluted medication is “pushed” by ...

#15. 11月2日Genet新聞:【中裕】終止與加拿大Theratechnologies ...

11月2日Genet新聞:【中裕】終止與加拿大Theratechnologies公司Trogarzo歐洲地區獨家行銷、【泰福】111年9月每股虧損0.35元 · Genet分析報導: · 生技公司買賣 ...

#16. New Trogarzo Administration Method Cuts Maintenance Dose ...

Theratechnologies ' Trogarzo® approved by FDA for 30-second intravenous (IV) push, simplifying HIV treatment for heavily ...

#17. 中裕合作夥伴終止歐洲銷售目標年底前尋新合作對象 - 永豐金證券

中裕(4147-TW) 與合作夥伴Theratechnologies 終止愛滋病新藥Trogarzo 在歐洲的銷售...

#18. Trogarzo (ibalizumab-uiyk) FDA Approval History - Drugs.com

Oct 3, 2022, Approval Theratechnologies' Trogarzo Approved by FDA for 30-Second Intravenous (IV) Push, Simplifying HIV Treatment for Heavily ...

#19. Label: TROGARZO- ibalizumab injection, solution - DailyMed

Packager: Theratechnologies Inc. Category: HUMAN PRESCRIPTION DRUG LABEL; DEA Schedule: None; Marketing Status: Biologic Licensing Application ...

#20. Trogarzo (ibalizumab-uiyk) - CenterWatch

Contact: Theratechnologies. Website: www.trogarzo.com ... Trogarzo (ibalizumab-uiyk) is a CD4-directed post-attachment HIV-1 inhibitor.

#21. About TROGARZO™ (ibalizumab-uiyk) Injection - MultiVu

TROGARZO ™ (ibalizumab-uiyk) Injection. ... TROGARZO™ Fact Sheet. Multidrug Resistance Infographic. TROGARZO™ FAQ ... TROGARZO.com www.theratech.com.

#22. EX-99.2 - SEC.gov

Theratechnologies and TaiMed Biologics Inc. (TaiMed) are also evaluating an intramuscular (IM) method of administration for Trogarzo ® within the TMB-302 ...

#23. Theratechnologies Receives FDA Approval For Intravenous ...

(RTTNews) - Theratechnologies Inc. (THTX), a biopharmaceutical company ... of its antiretroviral medication Trogarzo for the treatment of H.

#24. Theratechnologies Trogarzo® Data at ... - The Globe and Mail

Detailed price information for Theratechnologies Inc (THTX-Q) from The Globe and Mail including charting and trades.

#25. National Bank on FDA Approval of Theratechnologies' Trogarzo

Theratechnologies announced that its intravenous Push administration of Trogarzo has been approved by the U.S. FDA following a Biologics ...

#26. 《生醫股》中裕終止與Theratechnologies公司Trogarzo歐洲 ...

【時報-台北電】中裕(4147)公告終止與Theratechnologies公司Trogarzo歐洲地區獨家行銷權利。中裕與加拿大Theratechnologies公司於2016年3月簽訂12年期 ...

#27. Theratechnologies Trogarzo® Data at AIDS 2022 Shows ...

New sub-analysis on Trogarzo clinical trial patients demonstrates that long-term viral suppression is not influenced by partially active ...

#28. Theratechnologies' Trogarzo Receives FDA ... - ChemDiv

Montreal, Canada-based Theratechnologies has received FDA's approval for Trogarzo (ibalizumab-uiyk) for administration by intravenous (IV) push.

#29. Theratechnologies' 'Champions' showcases minority HIV ...

HIV drugmaker Theratechnologies' new campaign, I Am a Champion, ... Theratechnologies, which markets HIV treatments Trogarzo and Egrifta SV, ...

#30. Trogarzo (ibalizumab; Theratechnologies/TaiMed Biologics ...

Drug Overview Trogarzo (ibalizumab; Theratechnologies/TaiMed Biologics) is a recombinant humanized monoclonal antibody approved for the treatment of HIV-1.

#31. TROGARZO™ Enrollment Form - Florida Department of Health

I have prescribed TROGARZO™ based on my judgment of medical ... Theratechnologies Inc., to perform a preliminary assessment of insurance verification and ...

#32. Theratechnologies pulls of out Europe, taking ibalizumab with it

Accordingly, the company will be ceasing the sale of their monoclonal antibody based HIV treatment ibalizumab (trade name Trogarzo) in Europe. The company ...

#33. Ibalizumab: Uses, Interactions, Mechanism of Action - DrugBank

It has been developed by Taimed biologics and Theratechnologies. ... In October 2022, the FDA approved the administration of Trogarzo (ibalizumab-uiyk) by ...

#34. 中裕愛滋新藥歐洲有進展 - 中華民國製藥發展協會

中裕說，用於治療愛滋病新藥Trogarzo的加拿大行銷夥伴Theratechnologies昨日通知中裕此一進度，並確認已取得歐盟藥品管理局（EMA）同意Theratechnologies「延遲兒童三 ...

#35. 美FDA核准中裕愛滋病新藥Trogarzo靜脈推注新劑型上市

依據中裕新藥與合作夥伴Theratechnologies公司協議，靜脈推注劑型獲准上市後，中裕新藥將可分兩年共取得300萬美元（約新台幣9,500萬元）研發哩程金。

#36. Trogarzo - Positively Aware

Dose modifications of Trogarzo are not required when administered with any other antiretroviral or ... Theratechnologies Inc. theratech.com; trogarzo.com ...

#37. BRIEF-Theratechnologies Announces FDA Approval ... - Reuters

THERATECHNOLOGIES ANNOUNCES FDA APPROVAL OF BREAKTHROUGH THERAPY, TROGARZO™ (IBALIZUMAB-UIYK) INJECTION, THE FIRST HIV-1 INHIBITOR AND ...

#38. Theratechnologies Inc. (THTX) Q3 2022 Earnings Call Transcript

So, the approval of Trogarzo for IV push could not have come at a better time. Incidentally, Theratechnologies announced data from two ...

#39. Marketed Drugs - Theratechnologies Inc - GlobalData

ibalizumab, ibalizumab-uiyk, Trogarzo, Theratechnologies Inc, Infectious Disease, Human Immunodeficiency Virus (HIV) Infections (AIDS), Marketed, Belgium.

#40. 中裕新藥歐洲上市獲里程碑金1.39億

中裕4日公告，受惠愛滋病新藥Trogarzo去年在歐洲上市，取得授權行銷夥伴Theratechnologies里程碑金500萬美元（約新台幣1.39億元），EPS貢獻約0.55元， ...

#41. Theratechnologies Inc.: Specialized Therapies | HIV and ...

Theratechnologies is a clinical-stage biopharmaceutical company focused on the development ... Trogarzo® and EGRIFTA SV® are approved in the United States.

#42. FDA Approves HIV-1 Treatment Ibalizumab for 30-Second IV ...

The Food and Drug Administration (FDA) has approved the HIV-1 medication ibalizumab-uiyk (Trogarzo, Theratechnologies Inc) for ...

#43. 擬退回Trogarzo歐洲地區獨家行銷權利 - 玉山證券

本公司與加拿大Theratechnologies Inc.於2016年3月簽訂12年期愛滋病新藥Trogarzo美國及加拿大地區（以下簡稱北美地區）獨家銷售行銷契約，內容包括 ...

#44. Trogarzo - Theratechnologies Europe Limited

商品名称, Trogarzo. 适用类别, Human. 治疗领域, HIV Infections. 通用名/非专利名称, ibalizumab. 活性成分, Ibalizumab. 产品号, EMEA/H/C/004961.

#45. TH-TSX Pandemic Minimally Impede FQ420 Egrifta-Trogarzo ...

QC-based endocrinology/oncology drug developer. Theratechnologies provided both a financial and clinical update on operations this morning. The ...

#46. Theratechnologies Announces FDA Approval of ... - Markets Insider

In combination with other ARTs, Trogarzo™ is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in heavily treatment- ...

#47. Trogarzo® Phase III Data Analysis featured During Late ...

(Theratechnologies) (TSX: TH) announced that additional analysis of phase III clinical trial data of Trogarzo® (ibalizumab-uiyk) injection was ...

#48. Theratechnologies Sets $118k Yearly Price For HIV Biologic ...

in 2016 for $2m up front, is touting Trogarzo as the first biologic and monoclonal antibody approved for HIV and the first HIV therapy that ...

#49. Ibalizumab Trogarzo - Treatment - National HIV Curriculum

TROGARZO does not contain any preservative. TROGARZO vial stopper is not made with natural rubber latex. Manufactured by Theratechnologies Inc., ...

#50. 中裕愛滋病新藥靜脈注射劑型通過歐盟藥證 - Bio@Taipei

中裕新藥公告愛滋病新藥Trogarzo（TMB-355）靜脈注射劑型已經正式獲得歐盟執委 ... 105 年3 月與加拿大Theratechnologies 公司簽訂為期12 年的愛滋病新藥TMB-355 美國 ...

#51. Theratechnologies assemble science team to retool phase 1

Theratechnologies has formed a science advisory committee to try and ... Theratechnologies has two approved medicines: Trogarzo for HIV-1 ...

#52. Trogarzo® (Ibalizumab-Uiyk) - UHCprovider.com

Montreal, Quebec, Canada: Theratechnologies, Inc. April 2021. 2. Emu B, Fessel J, Schrader S, et al. Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV- ...

#53. Option Care Selected as the Home and Alternate Site Infusion ...

... has been selected by Theratechnologies Inc. as an infusion provider for TrogarzoTM (ibalizumab-uiyk) Injection, an intravenous (IV) infusion for the ...

#54. TaiMed Biologics bullish on Trogarzo after EU body approves ...

HIV/AIDS TREATMENT: A TaiMed official said the firm's marketing partner Theratechnologies is to negotiate with regulatory bodies in the ...

#55. Trogarzo - FEPBlue

Trogarzo (ibalizumab-uiyk) is a recombinant humanized monoclonal antibody that ... Montreal, Canada: Theratechnologies, Inc.; October 2022.

#56. 愛滋防治宣導-財團法人台灣紅絲帶基金會-篩檢諮詢

針對Trogarzo靜脈推注劑型，中裕預計一個月內向FDA提出藥證申請，最快明年初取得藥證，中裕可獲得Theratechnologies公司300萬美元研發哩程金及後續銷售分潤。

#57. THERA PATIENT SUPPORT

Please see the full Prescribing Information at TROGARZO.com. PRIVACY POLICY · TERMS OF USE · THERATECHNOLOGIES. THERA patient support ™. © ...

#58. FDA Approves New Administration Method for Trogarzo in HIV

The FDA has approved Thera Technologies' “push” administration of Trogarzo (ibalizumab-uiyk) to treat patients with human immunodeficiency ...

#59. THERATECHNOLOGIES TO FOCUS ITS ...

CNW Telbec/ - Theratechnologies Inc. (Theratechnologies or Company) ... will cease its Trogarzo® commercialization operations in Europe.

#60. Trogarzo (ibalizumab-uiyk) for the Treatment of Multidrug ...

Trogarzo ™ is indicated for the treatment of multidrug-resistant HIV-1 infection in heavily ... Image courtesy of Theratechnologies.

#61. Theratechnologies (@Theratech_) / Twitter

Theratechnologies (TSX: TH) (NASDAQ: THTX) is a commercial-stage ... Supported by 9% Growth in EGRIFTA SV ® Revenue and 5% Growth in Trogarzo ® Revenue ...

#62. Ibalizumab - KEGG DRUG

Entry. D09575 Drug · Name. Ibalizumab (USAN/INN); Ibalizumab-uiyk; Trogarzo (TN) · Abbr. IBA · Product. TROGARZO (Theratechnologies) · Sequence. (Heavy chain)

#63. FDA approves Trogarzo for MDR HIV - Healio

Trogarzo (ibalizumab-uiyk), which was developed by Theratechnologies in partnership with TaiMed Biologics, is the first HIV therapy with a ...

#64. Trogarzo™ Information Sheet for Patients and Providers

California AIDS Drug Assistance Program (CA ADAP): Trogarzo™ Information ... and your doctor will submit this to TheraTechnologies (the.

#65. Theratechnologies Announces FDA Approval ... - PR Newswire

Trogarzo ™ is a humanized monoclonal antibody for the treatment of multidrug resistant HIV-1 infection. Trogarzo™ binds primarily to the second ...

#66. THERATECHNOLOGIES TO FOCUS ITS ... - AP News

(TaiMed) as per our contractual obligations and will return the European commercialization rights to Trogarzo® for TaiMed within the next 180 ...

#67. TROGARZO® Enrollment Form - NeedyMeds

I have received the necessary authorization prior to the transmittal of health information to Theratechnologies Inc., and parties working with.

#68. Trogarzo™ (ibalizumab-uiyk) - OHSU

Trogarzo 200 mg single-dose vial: 10 vials initially followed by 4 vials ... Montreal, Quebec Canada; Theratechnologies, Inc.; May 2018.

#69. Ibalizumab (Trogarzo) | aidsmap

Ibalizumab (Trogarzo) is a laboratory-manufactured antibody that binds to ... Ibalizumab is manufactured and marketed by Theratechnologies.

#70. HIV approval thrusts Theratechnologies into the limelight

That company is Canada's Theratechnologies, which thanks to US approval of Trogarzo looks set to become the world's fifth-biggest HIV player ...

#71. Theratechnologies Reports Financial Results and Business ...

Q1 2023 Consolidated Revenue Grew 7%, Supported by 9% Growth in EGRIFTA SV(R) Revenue and 5% Growth in Trogarzo(R) Revenue -- Revised ...

#72. Company Announcements | Theratechnologies - InvestEgate

Date Time Source Company 26 Oct 2021 7:00 am GNW Theratechnologies 30 Sep 2020 9:01 pm GNW Theratechnologies 10 Sep 2020 7:00 am GNW Theratechnologies

#73. IDV to THERATECHNOLOGIES INC - USAspending

36C24921N0223 · Department of Veterans Affairs, DELIVERY ORDER, $17,007, 11/27/2020, 11/27/2020, TROGARZO (PHARMACEUTICAL).

#74. Theratechnologies (THTX) Trogarzo Approved by FDA for 30 ...

Theratechnologies (THTX) Trogarzo Approved by FDA for 30-Second Intravenous (IV) Push, Simplifying HIV Treatment for Heavily Treatment- ...

#75. Trogarzo (ibalizumab-uiyk) – New orphan drug approval

Trogarzo. ™. (ibalizumab-uiyk) – New orphan drug approval. • On March 6, 2018, the FDA announced the approval of Theratechnologies and TaiMed Biologics'.

#76. Theratechnologies, Taimed get FDA nod, and several firsts, for ...

Trogarzo (ibalizumab-uiyk) became the first HIV treatment with a new mechanism of action in more than a decade to gain FDA approval.

#77. 新聞本文

(4147)中裕公告本公司愛滋病新藥Trogarzo靜脈推注劑型(IV Push)獲得美國FDA ... 本次臨床試驗及法規申請等相關費用全數由Theratechnologies公司負擔。

#78. 免费的新药情报数据库 - PatSnap Synapse

Theratechnologies Presents Results From Trogarzo® IV Push Administration Study at CROI 2022. 2022-02-16. ·BioSpace. 抗体引进/卖出.

#79. 中裕愛滋新藥獲美核准 - 社團法人中華民國學名藥協會

由於此次FDA核准Trogarzo藥價(whole sales price)為每人每年11.8萬 ... 不過，看好TMB-355的後市，中裕目前尚未決定處分Theratechnologies股票。

#80. Theratechnologies to Focus Its Commercialization Activities ...

This decision will in no way impact our commitment to providing our innovative medicines, Egrifta SV ® and Trogarzo®, to North American patients, ...

#81. Ibalizumab approved in the EU | HTB - HIV i-Base

Ibalizumab was developed by TaiMed Biologics with the trade name Trogarzo. It is marketed by Theratechnologies.

#82. THERA patient support® Service/Support Center (HUB)

Websites: • Trogarzo.com. • Therapatientsupport.com. • EgriftaSV.com. Copyright© 2020. All Rights Reserved. Confidential Property of Theratechnologies Inc.

#83. Pharmacist Medication Insights: Ibalizumab (Trogarzo) for HIV

Ibalizumab-uiyk (Trogarzo, Theratechnologies) is an injectable CD4-directed post-attachment HIV-1 inhibitor for the treatment of HIV type 1 ...

#84. Ibalizumab-uiyk (Trogarzo) for Multidrug-Resistant HIV

The FDA has approved ibalizumab-uiyk (Trogarzo – Theratechnologies/TaiMed), a CD4-directed monoclonal antibody, for IV treatment of ...

#85. Theratechnologies' last-ditch HIV drug approved by FDA

Theratechnologies Trogarzo (ibalizumab-uiyk) has been given the green light by the FDA as an add-on treatment for people who have had a lot ...

#86. Theratechnologies' HIV drug Trogarzo shows long-term viral ...

Theratechnologies Inc. said its medicine Trogarzo, or ibalizumab, continued to suppress HIV levels in certain patients, preventing the virus ...

#87. Theratechnologies inks agreement with Italian Medicines ...

Theratechnologies inks agreement with Italian Medicines Agency for reimbursement of Trogarzo for eligible patients with multi-drug resistant ...

#88. Trogarzo (Ibalizumab-uiyk Injection) - RxList

Once diluted, the TROGARZO solution should be administered immediately [see DOSAGE AND ADMINISTRATION]. Manufactured by: Theratechnologies Inc., ...

#89. Ibalizumab video series 3: Ibalizumab mechanism of action

Ibalizumab video series 3: Ibalizumab mechanism of action. 4.1K views 5 years ago. Theratechnologies Inc. Theratechnologies Inc.

#90. Virologic Failure in HIV: An Updated Clinician’s Guide to ...

TaiMed receives from Theratechnologies notification of returning commercialization rights for Trogarzo in European territory. News release.

#91. Briggs Drugs in Pregnancy and Lactation: A Reference Guide ...

Reference. 1. Product information. Trogarzo. Theratechnologies, 2019. IBANDRONATE. (Boniva). IBANDRONATE. Bisphosphonate PREGNANCY RECOMMENDATION: Limited ...

#92. Biotechnology: the Science, the Products, the Government, ...

Anthrax Anthim Obiltoxaximab Elusys Anthrax Synagis Pavivizumab Astrazeneca & SOBI RSV Trogarzo Ibilizumab TheraTechnologies HIV Zinplava Bezlotoxumab Merck ...

#93. 遠東生技董事長- 2023 - worry.pw

... (股)公司執行副總經理、遠市場觀測️中裕(4147)愛滋病新藥Trogarzo肌肉注射三期 ... 預計Q3解盲️中裕(4147)收到Theratechnologies公司預告退回愛滋病新藥Trogarzo ...

#94. 遠東生技董事長2023 - sakofako.online

... 中裕(4147)愛滋病新藥Trogarzo肌肉注射三期臨床試驗收案完成、預計Q3解盲️中裕(4147)收到Theratechnologies公司預告退回愛滋病新藥Trogarzo歐洲 ...